High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy

Published:2016-02-24 Issue:7 Volume:65 Page:813-819
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Kalathil Suresh Gopi,Thanavala Yasmin

Funder

National Cancer Institute (NCI) Core Grant to Roswell Park Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-016-1810-0.pdf

Reference47 articles.

1. Schrader J (2013) The role of MDSCs in hepatocellular carcinoma—in vivo veritas? J Hepatol 59:921–923

2. Capece D, Fischietti M, Verzella D, Gaggiano A, Cicciarelli G, Tessitore A et al (2013) The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. Biomed Res Int 2013:187204. doi: 10.1155/2013/187204

3. Cabrera R, Szabo G (2013) Another armed CD4(+) T cell ready to battle hepatocellular carcinoma. Hepatology 58:1–3

4. Fu J, Zhang Z, Zhou L, Qi Z, Xing S, Lv J et al (2013) Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma. Hepatology 58:139–149

5. Pastille E, Bardini K, Fleissner D, Adamczyk A, Frede A, Wadwa M et al (2014) Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. Cancer Res 74:4258–4269

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in nucleic acid therapeutics: structures, delivery systems, and future perspectives in cancer treatment;Clinical and Experimental Medicine;2024-08-28

2. Survival and safety analysis of COVID‐19 vaccine in Chinese patients with non‐small cell lung cancer;Cancer Medicine;2024-04

3. Recent advances in therapeutic engineered extracellular vesicles;Nanoscale;2024

4. Signal sequence receptor subunit 3: A novel indicator of immunosuppressive tumor microenvironment and clinical benefits from immunotherapy;Cellular Signalling;2023-11

5. Activation of T Lymphocytes with Anti-PDL1-BiTE in the Presence of Adipose-Derived Mesenchymal Stem Cells (ASCs);BioMed Research International;2023-06-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3